|Number of pages||1|
|Journal||Journal of Clinical Oncology|
|Publication status||Published - 20 May 2015|
|Event||Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer - Chicago, Israel|
Duration: 29 May 2015 → 2 Jun 2015
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer. (ISRCTN 12808747) TRAPEZE.
Nicholas David James, Lazaros Andronis, Ilias Goranitis, Sarah Pirrie, Ann Pope, Darren Barton, Adam Daunton, Duncan McLaren, Joe M. O'Sullivan, Chris Parker, John Staffurth, Andrew Stanley, James Wylie, Sharon Beesley, Alison J. Birtle, Janet Elizabeth Brown, Prabir R. Chakraborti, John Martin Russell, Lucinda Billingham
Research output: Contribution to journal › Meeting abstract › peer-review